Literature DB >> 3418979

A study on the mechanism of anemia and leukopenia in liver cirrhosis.

I Ohki1, K Dan, S Kuriya, T Nomura.   

Abstract

To elucidate the mechanism of anemia and leukopenia in the patients with liver cirrhosis, we investigated hematopoietic progenitor cell contents in their bone marrow, and the effects of their sera and blood mononuclear cells on hematopoietic progenitors from normal subjects. While there was no significant difference in the number of marrow CFU-E and BFU-E between the patients with liver cirrhosis and normal subjects, the number of marrow CFU-C was significantly reduced in liver cirrhosis patients. Patients' sera suppressed in vitro colony formation of normal CFU-E, BFU-E, and CFU-C, and the degree of suppression was well correlated with severity of anemia or granulocytopenia. In vitro colony formation of normal hematopoietic progenitor cells was not affected by blood mononuclear cells from liver cirrhosis patients. These results indicate that the appearance of humoral inhibitor(s) of hematopoietic progenitors plays a role in the development of anemia and granulocytopenia in liver cirrhosis.

Entities:  

Mesh:

Year:  1988        PMID: 3418979     DOI: 10.2169/internalmedicine1962.27.155

Source DB:  PubMed          Journal:  Jpn J Med        ISSN: 0021-5120


  5 in total

1.  Renal insufficiency may partly explain chronic anemia in patients awaiting liver transplantation.

Authors:  Cary H Patt; Kyrsten D Fairbanks; Paul J Thuluvath
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

Review 2.  Systemic abnormalities in liver disease.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2009-06-28       Impact factor: 5.742

3.  Alterations in the erythrocyte plasma membranes in patients with alcohol-induced liver cirrhosis - preliminary results.

Authors:  Lukasz Gwoździński; Piotr Krawczyk; Daniela Dworniak; Edward Kowalczyk; Jan Błaszczyk
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

4.  Hypersplenism in liver disease and SLE revisited: current evidence supports an active rather than passive process.

Authors:  John M Gemery; Andrew R Forauer; Anne M Silas; Eric K Hoffer
Journal:  BMC Hematol       Date:  2016-02-09

5.  Anti-tumor effect of polysaccharide from Pleurotus ostreatus on H22 mouse Hepatoma ascites in-vivo and hepatocellular carcinoma in-vitro model.

Authors:  Kavish Hasnain Khinsar; Sattar Abdul; Akbar Hussain; Riaz Ud Din; Liu Lei; Jing Cao; Majid Abbasi; Ata Ur Rehman; Nabeel Farooqui; Xin Yi; Huang Min; Liang Wang; Zhong Mintao
Journal:  AMB Express       Date:  2021-12-02       Impact factor: 3.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.